Syngen Biotech Co.,Ltd. Syngen Biotech Co.,Ltd.

Syngen Biotech Co.,Ltd.

8279

Rank in Stocks #21455
Established in 1988 and based in Tainan City, Taiwan, Syngen Biotech Co.,Ltd.... Established in 1988 and based in Tainan City, Taiwan, Syngen Biotech Co.,Ltd. operates globally, including in Taiwan and China, specializing in the research, development, production, and sale of a diverse array of products. Its core offerings include microbial pharmaceutical raw materials, biological pesticides, fertilizers, biochemical nutritional products, and preventive medicines. The company further manufactures dietary supplements and provides comprehensive contract manufacturing services for supplements, accommodating various formats such as sachets, liquids, tablets, cup package capsules, jellies, aluminum and glass bottles, and gummies. Syngen Biotech also develops and markets science-backed bioactive pharmaceutical ingredients (APIs) under proprietary brands including Oraltics, IMMUPHYLA, V3, ST4SanTex, GUARDSPO, benefiGANO, EXPUNERGY, and BIOJOVIAL. Additional services encompass private labelling, organic food OEM/ODM, explosion-proof extraction, brand agency, and wholesale distribution. Syngen Biotech caters to numerous industries, such as sport nutrition, beauty enhancement, baby and mother care, weight management, and digestion and detox. The company actively exports its products to approximately 20 countries worldwide.
Share Price
$2.35
Last synced: 2026-11-20
Market Cap
$63.47M
Change (1 day)
-2.66%
Change (1 year)
-44.90%
Country

Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this

Category

Healthcare
Operating Margin for Syngen Biotech Co.,Ltd. (8279)
Operating Margin as of November 2026 TTM: 12.15%
According to Syngen Biotech Co.,Ltd.'s latest financial reports, its current operating margin (TTM) is 12.15%. At the end of 2025 the company had an operating margin of 15.30%.
Operating Margin history for Syngen Biotech Co.,Ltd. from 2019 to 2026
Operating Margin at the end of each year
Year Operating Margin Change
2026 (TTM) 12.15% -20.59%
2025 15.30% 1.59%
2024 15.06% -5.99%
2023 16.02% -26.24%
2022 21.72% 6.89%
2021 20.32% 0.89%
2020 20.14% 7.59%
2019 18.72% 0.00%
Operating Margin for similar companies or competitors
Company Operating Margin Operating Margin Difference Country
33.87% -97.21%
US
-116.04% -109.55%
US
25.57% -97.90%
AU
29.35% -97.58%
NL
31.23% -97.43%
BE
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.

Questions about Syngen Biotech Co.,Ltd.'s operating margin

What is Syngen Biotech Co.,Ltd.'s operating margin?

Syngen Biotech Co.,Ltd.'s operating margin is 12.15%, as of Nov 2026.

What was Syngen Biotech Co.,Ltd.'s operating margin in 2025?

In 2025, Syngen Biotech Co.,Ltd.'s operating margin was 15.30%, compared with 15.06% in 2024.

How has Syngen Biotech Co.,Ltd.'s operating margin changed since 2020?

From 2020 to 2025, Syngen Biotech Co.,Ltd.'s operating margin was highest in 2022 (21.72%) and lowest in 2024 (15.06%).

How does Syngen Biotech Co.,Ltd.'s operating margin compare with similar companies?

Syngen Biotech Co.,Ltd.'s operating margin (12.15%) is higher than that of 1 of the 5 similar companies listed above. The highest among them is Vertex Pharmaceuticals Incorporated, with 33.87%.